GXH invests in health technology company PillDrop
NZX Release
13 September 2021
Green Cross Health invests in health technology company PillDrop
Healthcare company Green Cross Health Group has invested in an online pharmacy
business that sorts and delivers prescription medicine and provides care, advice and
support to customers. It has taken a 25 per cent shareholding in health technology
company PillDrop.
“Green Cross Health has invested in PillDrop to ensure we are adapting and working in
the new digital health environment. It’s part of our journey in the digital and telehealth
market and it complements our existing offer. It’s about keeping up with the changing
needs and wants of our customers,” says Group CEO Rachael Newfield.
All our divisions have seen increased demand for digital services in recent times.
Newfield said that PillDrop was a good fit for Green Cross Health as it aligns with our
brand promise to provide the best support, care and advice to our New Zealand
communities in a way they want to receive it.
PillDrop launched in 2020 and in that time has experienced strong growth. It has DHB
contracts across the country and is already providing a full-service digital direct-to-
consumer pharmacy solution. Green Cross Health’s investment ensures that the
trajectory is one that involves community pharmacy as part of the customers’ complete
health profile and remains an essential port of call for face-to-face healthcare and
advice.
Both companies say they are committed to the sustainability of the community
pharmacy sector and helping improve access to affordable healthcare. Newfield says,
“As the New Zealand health system undergoes transformation, our new partnership
with PillDrop further supports our strategy of focusing on the development of clinical
services and advice that enhance health outcomes and promote an equity approach.”
“We’ve been proactively in discussion with PillDrop for some time. We wanted to ensure
we are represented in this environment in a proactive way,” says Newfield.
PillDrop’s founders, Jack Lee and Suzanne Burge said Green Cross Health's investment
will support the company to expand the use of PillDrop services to more people across
the country, along with investments in additional technology.
- END -
Contact:
Ben Doshi
ben.doshi@gxh.co.nz
Rachael Newfield
rachael.newfield@gxh.co.nz
About Green Cross Health
Green Cross Health (NZX: GXH) is a trusted New Zealand primary healthcare provider
with multidisciplinary healthcare teams with the purpose of working together to
support healthier communities. Green Cross Health is focused on creating sustainable
healthcare solutions with positive outcomes and experiences. New Zealand owned and
operated, Green Cross Health operates under branded groups Unichem and Life
Pharmacies, The Doctors medical centres, Total Care Health community nursing
services and Access Community Health to provide support, care and advice to diverse
New Zealand communities. Providing convenient access to professional healthcare with
357 Unichem and Life pharmacies covering almost every New Zealand community,
Green Cross Health makes more than 3.7m home visits to more than 40,000 community
health clients and cares for 285,000 enrolled patients at medical centres.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: Cxbladder extends DHB coverage2021-07-06
“7 July 2021 CXBLADDER CONTINUES TO WIN OVER NZ PUBLIC HEALTHCARE PROVIDERS Northland District Health Board adopts full suite of Cxbladder tests Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has reached commercial agreement with Northland Distric…”
- PEB — Pacific Edge Limited: CXBLADDER EXTENDS COVERAGE OVER NZ HEALTHCARE PROVIDERS2021-08-02
“03 August 2021 CXBLADDER CONTINUES TO EXTEND COVERAGE OVER NZ PUBLIC HEALTHCARE PROVIDERS Taranaki District Health Board adopts full suite of Cxbladder tests Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has reached commercial agreement with Taranaki Distri…”
- PEB — Pacific Edge Limited: PE Dual Lists on ASX; Announces Capital Raise to Accelerate2021-09-22
“Company Announcement 23 September 2021 Pacific Edge has a well defined growth strategy and its primary focus remains to grow the adoption of multiple Cxbladder products by an increasing number of large scale institutional accounts in each of the company’s targeted markets. Po…”